Chaitanya Sanghadia

Mr. Chaitanya Sanghadia


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2023 in Biomechanics
Verified
Journal Article
Open access
PDF file
JCJohn Cerillo
John Cerillo
ABAlexander Becsey
Alexander Becsey
CSChaitanya Sanghadia
Chaitanya Sanghadia
KRKevin Thomas Root
Kevin Thomas Root
Brandon Lucke-WoldBrandon Lucke-Wold
Brandon Lucke-Wold
Spinal bracing is a common non-surgical technique that allows clinicians to prevent and correct malformations or injuries of a patient’s spinal column. This review will explore the current standards of practice on spinal brace utilization. Specifically, it will highlight bracing usage in traumatic injuries, pregnancy, pediatrics, osteoporosis, and hyperkyphosis; address radiological findings concurrent with brace usage; and provide an overview of the braces currently available and advancements in the field. In doing so, we aim to improve clinicians’ understanding and knowledge of bracing in common spinal pathologies to promote their appropriate use and improve patient outcomes.

29 December 2023
Verified
Journal Article
Open access
PDF file
CSChaitanya Sanghadia
Chaitanya Sanghadia
MMMelanie E. Martinez
Melanie E. Martinez
MMMarisa McNulty
Marisa McNulty
EREric Russ
Eric Russ
MWMaxwell Woolridge
Maxwell Woolridge
Brandon Lucke-WoldBrandon Lucke-Wold
Brandon Lucke-Wold
Hemangioblastoma are benign, vascularized cranial tumors caused by autosomal dominant inherited von Hippel-Lindau disease or can appear sporadically. This review will investigate current and emergin

23 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
CSChaitanya Sanghadia
Chaitanya Sanghadia
MNMilena Nicosia
Milena Nicosia
CCCaroline Castelino
Caroline Castelino
NTNeil Talwar
Neil Talwar
SKSafwan Kazmi
Safwan Kazmi
Brandon Lucke-WoldBrandon Lucke-Wold
Brandon Lucke-Wold
Brain metastases are the third most common metastatic site in melanoma patients, with 40% of melanoma patients developing melanoma brain metastasis (MBM). Symptomology of MBM ranges from headaches, neurological deficits, cognitive changes, and seizures, resulting from MBM embedding in areas of highest blood flow following the breakdown of the blood–brain barrier (BBB) via genetic, cytokine, and molecular processes. The BBB is highly restrictive, making MBM difficult to treat. Challenges in MBM treatment are evident in adverse therapeutic effects, such as neurocognitive decline with whole-brain radiation therapy (WBRT), increased risk of radiation necrosis with stereotactic radiosurgery (SRS), and reduced penetration into the brain, which can lead to drug resistance with prolonged use of MAPK inhibitors. This review investigates current and novel treatments against MBM, including radiotherapy, chemotherapy, targeted therapies such as BRAF/MAPK inhibitors, and immunotherapy.